fbpx | Page 20 | NDARC - National Drug and Alcohol Research Centre

Showing all projects

image - AARC Col Logo Square
Tags: alcohol Status: Completed
Governments, policy experts, researchers and randomly selected members of communities all support the idea of greater co-ordination of efforts aimed at reducing alcohol-related harm. Despite this... Read more
image - I30
Status: Completed
There is little detailed information about the Australian cannabis market, including the chemical characteristics of the locally available cannabis product. The collection of accurate and current... Read more
image - ACT Map 280 1
Status: Completed
This project aimed to determine whether existing ACT legal thresholds for drug offences made sense in terms of the commercial realities of the drug market and, if not, to propose alternate threshold... Read more
image - Man %2B Women Counselling 280
Status: Completed
Suicide is a leading cause of death among people who misuse drugs and alcohol. The annual prevalence of attempted suicide among dependent drug users is equivalent to the lifetime prevalence in the... Read more
image - Blue Green Brain
Tags: opioids, opioid pharmacotherapy treatment (OPT) Status: Completed
This study compared the cognitive performance of opioid maintainance clients, abstinent ex-users of opioids, and healthy, non-heroin using controls. 
Image: Alcohol and violence
Tags: drug-related deaths Status: Completed
Alcohol consumption is strongly associated with premature mortality. The current study aimed to determine the strength of association between national per capita alcohol consumption with homicide and... Read more
image - Triple B 280 0
Status: Completed
The Triple B study (Bumps, Babies and Beyond) is a large NHMRC-funded birth cohort study which examines the effects of substance use in pregnant women and their partners during the prenatal period on... Read more
image - Suboxone280 By Brains The Head
Tags: opioid pharmacotherapy treatment (OPT) Status: Completed
The majority of buprenorphine-naloxone (Suboxone®) dosing in Australia involves supervised dosing of sublingual tablets in order to enhance medication adherence and to minimise aberrant behaviours... Read more